NCT04003467 - A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass | Biotech Hunter

Enrollment

161

Participants

Timeline

Start Date

June 30, 2019

Primary Completion Date

April 27, 2021

Study Completion Date

May 11, 2021

Conditions

Osteoporosis

Interventions

DRUG

EBP05

tablets

DRUG

Placebo of EBP05

tablets

Trial Locations (4)

Rabin Medical Center, Beilinson Campus, Petah Tikva

Sheba Medical Center, Ramat Gan

Tel-Aviv Sourasky Medical Center, Tel Aviv

Hadassah Medical Center, Mt. Scopus Hospital, Jerusalem